Acquisition / mergerFiled on BSE ·
Sudarshan Pharma terminates acquisition of 9.50% equity in Med Therapy Biotechnology Inc.
Sudarshan Pharma Industries Ltd · Chemicals & Petrochemicals
What the filing says
- Proposal to acquire 9.50% equity shares of Med Therapy Biotechnology Inc., USA, is terminated.
- Acquisition by promoters Hemal Mehta and Sachin Mehta also stands terminated.
- Filing dated 7th October 2026 updates previous letters dated 5th and 15th September 2026.
Original filing
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- Acquisition / mergerInox Green Energy Services LtdInox Green completes ₹550 crore payment for Wind World India’s 4.5 GW Wind O&M transfer
- Acquisition / mergerInox Green Energy Services LtdInox Green Energy Services acquires Wind World O&M business via Vibhav Energy
- Acquisition / mergerMaharashtra Seamless LtdMaharashtra Seamless Limited approves demerger scheme for two units into subsidiaries
- Acquisition / mergerSky Gold & Diam.Sky Gold & Diamonds acquires Purvi Gems for ₹9 crore to boost growth and diversification
- Acquisition / mergerSky Gold & Diam.Sky Gold and Diamonds completes acquisition of Purvi Gems & Jewellery Pvt Ltd
- Acquisition / mergerAdani Energy Solutions LtdAdani Energy Solutions acquires 100% stake in Satara Power Transmission Ltd
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.